KCNIP3
Reactivity: Human
WB, ELISA, IHC, IF
Host: Rabbit
Polyclonal
unconjugated
Application Notes
Immunofluorescence (1:10-50) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:50-100) Western Blot (1:1000) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Hong, Jo, Lee, Kim, Jung: "Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients." in: Neuroscience letters, Vol. 340, Issue 1, pp. 33-6, (2003) (PubMed).
Choi, Miller, Zaidi, Salih, Buxbaum, Wasco: "Phosphorylation of calsenilin at Ser63 regulates its cleavage by caspase-3." in: Molecular and cellular neurosciences, Vol. 23, Issue 3, pp. 495-506, (2003) (PubMed).
Schrader, Anderson, Mayne, Pfaffinger, Sweatt: "PKA modulation of Kv4.2-encoded A-type potassium channels requires formation of a supramolecular complex." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 22, Issue 23, pp. 10123-33, (2002) (PubMed).
Target
DREAM (KCNIP3)
(Kv Channel Interacting Protein 3, Calsenilin (KCNIP3))